A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

A groundbreaking deal will make a new HIV prevention drug affordable in over 100 low-income countries, potentially advancing global efforts to end the HIV/Aids epidemic.

Tick-borne encephalitis virus can infect the nervous system and cause life-threatening illness. Finding the cellular gateway ...

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...

HIV’s Tat protein blocks autophagy in macrophages, letting Mtb thrive. This may explain why HIV patients face higher TB risk even on ART.

Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Harnessing the power of AI, a research team at the MRC-University of Glasgow Center for Virus Research has launched ...

Globally, over half of people living with HIV are women. But in clinical cure trials, they make up only about 20% of ...

Skoltech researchers and their colleagues from the Pasteur Institute and the University of Lorraine, France, have uncovered ...

Viral infections continue to be a leading cause of morbidity and mortality in children. With emerging viruses, evolving ...